Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Fathers

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
British Journal of Hospital Medicine|May 4, 1996
Vasculitic neuropathyE Fathers, G N Fuller
Lancet (London, England)|September 5, 1998
Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob diseaseD A Hilton, E Fathers, P Edwards, et al.
Clinical & Experimental Metastasis|May 14, 2003
Angiogenesis and the role of epigenetics in metastasisBrenda L Coomber, Joanne L Yu, Kelly E Fathers, et al.
Molecular Cancer Research : MCR|April 16, 2005
CrkI and CrkII function as key signaling integrators for migration and invasion of cancer cellsSonia P Rodrigues, Kelly E Fathers, Gabriel Chan, et al.
Breast Cancer Research and Treatment|October 16, 2020
A population-based comparison of treatment patterns, resource utilization, and costs by cancer stage for Ontario patients with hormone receptor-positive/HER2-negative breast cancerChristine Brezden-Masley, Kelly E Fathers, Megan E Coombes, et al.
Current Oncology (Toronto, Ont.)|June 4, 2020
A population-based analysis of breast cancer incidence and survival by subtype in Ontario womenS J Seung, A N Traore, B Pourmirza, et al.
Breast Cancer Research and Treatment|October 22, 2020
A population-based comparison of treatment, resource utilization, and costs by cancer stage for Ontario patients with HER2-positive breast cancerChristine Brezden-Masley, Kelly E Fathers, Megan E Coombes, et al.
Cancer Medicine|August 31, 2020
A population-based comparison of treatment patterns, resource utilization, and costs by cancer stage for Ontario patients with triple-negative breast cancerChristine Brezden-Masley, Kelly E Fathers, Megan E Coombes, et al.
The American Journal of Pathology|December 17, 2009
CrkII transgene induces atypical mammary gland development and tumorigenesisKelly E Fathers, Sonia Rodrigues, Dongmei Zuo, et al.
The American Journal of Pathology|November 30, 2005
Heterogeneity of Tie2 expression in tumor microcirculation: influence of cancer type, implantation site, and response to therapyKelly E Fathers, Courtney M Stone, Kanwal Minhas, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
British Journal of Hospital Medicine|May 4, 1996
Vasculitic neuropathyE Fathers, G N Fuller
Lancet (London, England)|September 5, 1998
Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob diseaseD A Hilton, E Fathers, P Edwards, et al.
Clinical & Experimental Metastasis|May 14, 2003
Angiogenesis and the role of epigenetics in metastasisBrenda L Coomber, Joanne L Yu, Kelly E Fathers, et al.
Molecular Cancer Research : MCR|April 16, 2005
CrkI and CrkII function as key signaling integrators for migration and invasion of cancer cellsSonia P Rodrigues, Kelly E Fathers, Gabriel Chan, et al.
Breast Cancer Research and Treatment|October 16, 2020
A population-based comparison of treatment patterns, resource utilization, and costs by cancer stage for Ontario patients with hormone receptor-positive/HER2-negative breast cancerChristine Brezden-Masley, Kelly E Fathers, Megan E Coombes, et al.
Current Oncology (Toronto, Ont.)|June 4, 2020
A population-based analysis of breast cancer incidence and survival by subtype in Ontario womenS J Seung, A N Traore, B Pourmirza, et al.
Breast Cancer Research and Treatment|October 22, 2020
A population-based comparison of treatment, resource utilization, and costs by cancer stage for Ontario patients with HER2-positive breast cancerChristine Brezden-Masley, Kelly E Fathers, Megan E Coombes, et al.
Cancer Medicine|August 31, 2020
A population-based comparison of treatment patterns, resource utilization, and costs by cancer stage for Ontario patients with triple-negative breast cancerChristine Brezden-Masley, Kelly E Fathers, Megan E Coombes, et al.
The American Journal of Pathology|December 17, 2009
CrkII transgene induces atypical mammary gland development and tumorigenesisKelly E Fathers, Sonia Rodrigues, Dongmei Zuo, et al.
The American Journal of Pathology|November 30, 2005
Heterogeneity of Tie2 expression in tumor microcirculation: influence of cancer type, implantation site, and response to therapyKelly E Fathers, Courtney M Stone, Kanwal Minhas, et al.
Pageof 2